Laconext 100 Tablet contains Lacosamide 100mg, an antiepileptic agent indicated for the treatment of partial-onset seizures in patients with epilepsy. Lacosamide acts by selectively enhancing slow inactivation of voltage-gated sodium channels, stabilizing hyperexcitable neuronal membranes, and inhibiting repetitive neuronal firing. This mechanism contributes to its efficacy in reducing seizure frequency and severity. Laconext 100 is typically administered orally and can be used as monotherapy or adjunctive therapy in adults and pediatric patients aged 4 years and above. The dosage should be individualized based on clinical response and tolerability, with gradual titration recommended to minimize adverse effects. Common side effects include dizziness, headache, nausea, and fatigue, while serious adverse reactions are rare but may include cardiac conduction abnormalities; therefore, caution is advised in patients with pre-existing cardiac conditions. Lacosamide is contraindicated in patients with hypersensitivity to the active substance or any excipients. Regular monitoring of clinical status and potential drug interactions is essential during therapy. Laconext 100 Tablet should be stored in a cool, dry place away from direct sunlight and out of reach of children. Consultation with a healthcare professional is recommended before initiating treatment to ensure appropriate use and management.